Depression Therapeutics Market, By Drug Type, By Indication, By Distribution Channel, and By Geography

Description

The global depression therapeutics market is estimated to be valued at US$ 12.9 billion in 2023 and is expected to exhibit a CAGR of 4.5% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 12.9 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	4.50%	2030 Value Projection:	US$ 17.6 Bn

Global Depression Therapeutics Market Share (%), By Drug Type, 2023

Depression therapeutics are medications that can help relieve the symptoms of depression and are also used in the treatment of some other conditions. Antidepressants can treat the symptoms of depression or other mental health problems. But they don't always deal with the causes. Doctors will often prescribe them alongside talking therapy, to help deal with the causes of mental health problems. There are several different types of antidepressants. They mostly affect the same brain chemicals and cause similar effects. But some people may respond to certain antidepressants better than others.

The different types are:

Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs)
Tricyclics and tricyclic-related drugs
Monoamine Oxidase Inhibitors (MAOIs)
Others

Market Dynamics

The key players in the pharmaceutical industry are focusing on the development of drugs by conducting various clinical trials and research operations. Thus, increasing research and development activities by market players are expected to drive the growth of the global depression therapeutics market over the forecast period. For instance, in November 2022, Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, announced the initiation of dosing in the company's Phase 1 clinical trial of ABX-002 in healthy volunteers. ABX-002 is a potent and selective brain-boosting thyroid receptor beta (TRβ) agonist that Autobahn is evaluating as a potential adjunctive treatment for people with major depressive disorder (MDD) who are experiencing an inadequate response to their antidepressant.

Key features of the study:

This report provides an in-depth analysis of the global depression therapeutics market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global depression therapeutics market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Johnson & Johnson, GlaxoSmithKline plc., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited., Eli Lilly and Company, Sanofi S.A., Pfizer, Inc., Allergan plc., H. Lundbeck A/S, Alkermes, Allergan, Novartis AG, Biogen, Sage Therapeutics, Inc., and AbbVie Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global depression therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global depression therapeutics market.

Detailed Segmentation:

Global Depression Therapeutics Market, By Drug Type:
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Selective Norepinephrine Reuptake Inhibitors (SNRIs)
- Serotonin Modulators
- Tricyclic & Tetracyclic Antidepressants
- Atypical Antidepressants
- Antidepressants
- Antipsychotics
- Others
Global Depression Therapeutics Market, By Indication:
- Major Depressive Disorder (MDD)
- Bipolar Disorder
- Dysthymic Disorder
- Postpartum Depression
- Seasonal Affective Disorder (SAD)
- Premenstrual Dysphoric Disorder (PMDD)
- Others
Global Depression Therapeutics Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Depression Therapeutics Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Johnson & JohnsonGlaxoSmithKline plc.
- Otsuka Pharmaceutical Co., Ltd.
- Takeda Pharmaceutical Company Limited.
- Eli Lilly and Company
- Sanofi S.A.
- Pfizer, Inc.
- Allergan plc.
- H. Lundbeck A/S
- Alkermes
- Allergan
- Novartis AG
- Biogen
- Sage Therapeutics, Inc.
- AbbVie Inc.

Product Code: CMI1307

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities
- Impact Analysis
- Recent Drug Launches
- Epidemiology
- Pipeline Analysis
- Distribution Landscape
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis

4. Global Depression Therapeutics Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Depression Therapeutics Market, By Drug Type, 2018 - 2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Antidepressants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Serotonin Modulators
Tricyclic & Tetracyclic Antidepressants
Atypical Antidepressants
Antipsychotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends

6. Global Depression Therapeutics Market, By Indication, 2018 - 2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Major Depressive Disorder (MDD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Bipolar Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Dysthymic Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Postpartum Depression
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Seasonal Affective Disorder (SAD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Premenstrual Dysphoric Disorder (PMDD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends

7. Global Depression Therapeutics Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Depression Therapeutics Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
North America
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country/ Region, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
Johnson & Johnson
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
GlaxoSmithKline plc.
Otsuka Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Company Limited.
Eli Lilly and Company
Pfizer, Inc.
Allergan plc.
H. Lundbeck A/S
Alkermes
Allergan
Novartis AG
Biogen
Sage Therapeutics, Inc.
AbbVie Inc.

10. Section

References
Research Methodology
About us and Sales Contact